The latest headlines across every section, pulled from official and open-access sources.
Some cancers come back many years after successful treatment, often as metastatic disease. Researchers believe if and how this happens is heavily influenced by dormant cancer cells and their interaction with the immune system.
Plexin-B1 shapes glial networks around beta-amyloid plaques. An NIA-funded study has found that targeting it may improve plaque clearance and reduce brain inflammation.
A new drug targeting synaptic resilience shows potential in treating Alzheimer’s disease in an NIA-funded study, with early trials indicating safety and possible brain damage reduction. Further research is needed on the drug’s long-term effects.
Down syndrome (1:30), zuranolone for postpartum depression (7:50), muscle relaxants for chronic pain (10:20), temporal artery ultrasound (12:00), pretravel consultation (15:40), and high-flow nasal cannula for bronchiolitis (19:20).
How can diabetes health care professionals work with cardiologists to treat cardiovascular disease in people with diabetes? Learn more about managing heart disease and heart failure with lifestyle changes and medicines.
Dr. Centor discusses the evidence that implementation of the SEP-1 Bundle is associated with favorable outcomes for patients with sepsis with Drs. James Ford and Gabriel Wardi.
Researchers have developed a form of cancer treatment that uses fat cells engineered to aggressively consume nutrients like glucose. When implanted in mice, the engineered cells appeared to outcompete tumors for nutrients, shrinking tumors.
A modest cash-transfer intervention slowed memory decline and lowered dementia risk among midlife and older adults in rural South Africa.
Learn about the 2025 ADA Standards of Care in Diabetes, the latest clinical practice standards for diagnosing and providing care to people with diabetes.
Marking World TB Day 2025, this episode explores the data on tuberculosis in Europe based on the latest surveillance report, published recently by ECDC and WHO. Veronica Cristea, Scientific Officer at ECDC, discusses the overall TB situation in the EU/EEA, the impact of COVID-19, challenges in treatment success, and the concerning rise in TB cases among children. Veronica also highlights the steps needed to accelerate progress towards ending TB.Find out more about World TB Day here . For more information about ECDC in general, visit ecdc.europa.eu or follow us on social…
An advance care planning intervention increased both the documentation of end-of-life preferences and potentially burdensome care.
Dr. Centor discusses metabolic dysfunction-associated steatotic liver disease with Dr. Michelle Lai.
A study of Medicare data showed that roughly 9% of beneficiaries — 5.3 million people — may have Alzheimer’s disease or a related dementia.
NIA study reveals that nearly 42% of Americans over 55 may develop dementia, with new cases possibly doubling by 2060. Learn about the rising risk and future impact.
European adults with obesity who limited eating to any of three 8-hour window timeframes each day lost weight and improved cardiometabolic health.
This episode explores the growing threat of avian influenza, which has led to massive outbreaks in bird populations and an increasing number of cases in mammals. With nearly 70 human cases and one death confirmed in the US recently linked to the H5N1 subtype, concerns are rising about its potential to spread among humans in Europe and cause a pandemic. Experts from European Centre for Disease Prevention and Control (ECDC) and European Food Safety Authority (EFSA) discuss the risks to humans, the impact on animals, and the preventive measures that EU Member States can take. Listen in to…
How do obesity and type 2 diabetes affect heart and kidney health? Learn about how these conditions are connected, and how these links can affect your patients with type 2 diabetes.
A mother’s X chromosomes may turn off key genes, accelerate brain cell aging process, and impair learning and memory later in life.
An NIA-funded clinical trial investigating whether senolytics could improve bone health in older women had just subtle results.
NIA scientists developed an improved mouse model to study aging-related health decline, revealing how inflammation drives organ damage.